133 related articles for article (PubMed ID: 21052040)
1. Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.
Kemp DE; Calabrese JR; Eudicone JM; Ganocy S; Tran QV; McQuade RD; Marcus RN; Vester-Blokland E; Owen R; Carlson BX
Psychopharmacol Bull; 2010; 43(2):5-27. PubMed ID: 21052040
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
Kemp DE; Ganocy SJ; Brecher M; Carlson BX; Edwards S; Eudicone JM; Evoniuk G; Jansen W; Leon AC; Minkwitz M; Pikalov A; Stassen HH; Szegedi A; Tohen M; Van Willigenburg AP; Calabrese JR
J Affect Disord; 2011 Apr; 130(1-2):171-9. PubMed ID: 21071096
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive aripiprazole for depression: predictive value of early assessment.
Muzina DJ; Chambers JS; Camacho TA; Eudicone JM; Forbes RA; Berman RM; Baker RA
Am J Manag Care; 2011 Dec; 17(12):793-801. PubMed ID: 22216750
[TBL] [Abstract][Full Text] [Related]
4. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.
Nelson JC; Rahman Z; Laubmeier KK; Eudicone JM; McQuade RD; Berman RM; Marcus RN; Baker RA; Sheehan JJ
CNS Spectr; 2014 Dec; 19(6):528-34. PubMed ID: 24642260
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
[TBL] [Abstract][Full Text] [Related]
8. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
Steffens DC; Nelson JC; Eudicone JM; Andersson C; Yang H; Tran QV; Forbes RA; Carlson BX; Berman RM
Int J Geriatr Psychiatry; 2011 Jun; 26(6):564-72. PubMed ID: 20827794
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
Keck PE; Calabrese JR; McQuade RD; Carson WH; Carlson BX; Rollin LM; Marcus RN; Sanchez R;
J Clin Psychiatry; 2006 Apr; 67(4):626-37. PubMed ID: 16669728
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
13. A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.
El-Mallakh RS; Marcus R; Baudelet C; McQuade R; Carson WH; Owen R
J Affect Disord; 2012 Feb; 136(3):258-66. PubMed ID: 22209190
[TBL] [Abstract][Full Text] [Related]
14. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
15. Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010).
Masand PS; Eudicone J; Pikalov A; McQuade RD; Marcus RN; Vester-Blokland E; Carlson BX
Psychopharmacol Bull; 2008; 41(2):12-23. PubMed ID: 18668014
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA
Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
Thase ME; Bowden CL; Nashat M; Eudicone JM; Marcus R; McQuade RD; Carlson BX
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):121-31. PubMed ID: 22296512
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
Findling RL; Correll CU; Nyilas M; Forbes RA; McQuade RD; Jin N; Ivanova S; Mankoski R; Carson WH; Carlson GA
Bipolar Disord; 2013 Mar; 15(2):138-49. PubMed ID: 23437959
[TBL] [Abstract][Full Text] [Related]
20. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
